Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00011362 · ClinicalTrials.gov registry record · Phase 3
Dexamethasone Therapy in VLBW Infants at Risk of CLD
A Phase 3 study, sponsored by NICHD Neonatal Research Network.
- Completed
- Registry status
- Phase 3
- Development phase
- 371
- Enrollment target
NCT00011362: Completed Phase 3 study, sponsored by NICHD Neonatal Research Network.
NCT00011362 is a Phase 3 study that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 371 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00011362, a Phase 3 study, has completed, sponsored by NICHD Neonatal Research Network.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 371 participants
- Enrollment target
Study Summary
Infants who are on breathing support are often treated with steroids (dexamethasone); however, the best timing of therapy is not known. This trial looked at the benefits and hazards of starting dexamethasone therapy at two weeks of age and four weeks of age in premature infants.
Interventions
- DRUG Dexamethasone Early
- DRUG Dexamethasone Late
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 1992-09 |
| Est. Completion | 1994-04 |
| Phase | Phase 3 |
What the finished NCT00011362 record still lists
NCT00011362 is an interventional study that assigns participants to a tested intervention. The registered 371 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (52% lower).
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone Early is the first listed.
NCT00011362 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00011362 about?
NCT00011362 is a clinical study titled "Dexamethasone Therapy in VLBW Infants at Risk of CLD". Infants who are on breathing support are often treated with steroids (dexamethasone); however, the best timing of therapy is not known. This trial looked at the benefits and hazards of starting dexamethasone therapy at two weeks of age and four weeks of age in premature infants.
What is the current status of trial NCT00011362?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 371 participants. The study started on 1992-09. Estimated completion is 1994-04.
What interventions are being tested in trial NCT00011362?
The interventions under investigation include: Dexamethasone Early (DRUG), Dexamethasone Late (DRUG).
Who is sponsoring clinical trial NCT00011362?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00011362's enrollment target sits among peer trials
371 992nd of 2000 higher than 1,008 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05743673 · 371 participants
SHAPE Test for Preoperative Risk Stratification
- NCT05761847 · 371 participants · NA
Pediatric Medication Therapy Management Trial
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia